tiprankstipranks
Trending News
More News >
AlphaTON Capital (ATON)
NASDAQ:ATON
US Market
Advertisement

AlphaTON Capital (ATON) Price & Analysis

Compare
127 Followers

ATON Stock Chart & Stats


ATON FAQ

What was AlphaTON Capital’s price range in the past 12 months?
AlphaTON Capital lowest stock price was $2.95 and its highest was $15.82 in the past 12 months.
    What is AlphaTON Capital’s market cap?
    AlphaTON Capital’s market cap is $13.10M.
      When is AlphaTON Capital’s upcoming earnings report date?
      AlphaTON Capital’s upcoming earnings report date is Dec 02, 2025 which is in 56 days.
        How were AlphaTON Capital’s earnings last quarter?
        Currently, no data Available
        Is AlphaTON Capital overvalued?
        According to Wall Street analysts AlphaTON Capital’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does AlphaTON Capital pay dividends?
          AlphaTON Capital does not currently pay dividends.
          What is AlphaTON Capital’s EPS estimate?
          AlphaTON Capital’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does AlphaTON Capital have?
          AlphaTON Capital has 2,278,622 shares outstanding.
            What happened to AlphaTON Capital’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of AlphaTON Capital?
            Currently, no hedge funds are holding shares in ATON

            Company Description

            AlphaTON Capital

            AlphaTON Capital Corp. is the rebranded entity formerly known as Portage Biotech Inc., a clinical-stage immuno-oncology company transitioning into a digital asset treasury model focused on accumulating and staking Toncoin (TON). AlphaTON intends to invest significantly in TON tokens, targeting a Long-Term TON treasury of approximately US $100 million.

            AlphaTON Capital (ATON) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Can-Fite BioPharma
            Phio Pharmaceuticals
            Cellectar Biosciences
            MetaVia
            Bolt Biotherapeutics

            Ownership Overview

            <0.01%0.85%99.15%
            Insiders
            0.85% Other Institutional Investors
            99.15% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis